December 17 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday that its CEO Ognyan Donev acquired 13,892 shares in the company at a weighted average price of 3.20 levs ($1.97/1.62 euro) on December 16.